• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Diabetes

Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage

October 31, 2025 By Sean Whooley

Dexcom G7 iPhone (1)

Amid some scrutiny over its latest-generation G7 continuous glucose monitor (CGM), Dexcom (Nasdaq:DXCM) officials addressed claims on the company’s latest earnings call. A recent class action lawsuit brought G7 into the spotlight, demanding a jury trial for claims that Dexcom’s representations for G7 were false, misleading, and deceptive to consumers. The lawsuit says G7 places […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Modular Medical is seeking CE mark for its next-gen insulin pump

October 31, 2025 By Sean Whooley

Modular Medical Pivot insulin patch pump

Modular Medical (Nasdaq:MODD) announced that it continues to progress toward CE mark for its Pivot insulin pump system. The San Diego-based company said it completed its Stage 1 ISO 13485:2016 audit, conducted by BSI, its Notified Body and Registrar. This audit evaluated its quality management system for compliance and alignment with EU MDR requirements. It […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance Tagged With: modularmedical

CGM market report: Significant growth is ahead

October 30, 2025 By Sean Whooley

This is the cover of the MassDevice Medtech Markets Intelligence Report about the CGM market.

As millions of people worldwide seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow rapidly. Medtech market analysts project significant growth for the market over the next five years. Chrystal Larsen, a veteran medtech market analyst, produced a detailed report for MassDevice outlining the future of the CGM market. The report covers […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Dexcom, Medtronic, Senseonics

Dexcom stock is down after hours despite Q3 beats, raised sales guidance

October 30, 2025 By Sean Whooley

Dexcom updated Logo

Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of DXCM fell more than 8% to $62.69 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $283.8 million. That equals 70¢ per share on sales […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Insulet launches inclusion campaign for Diabetes Awareness Month

October 30, 2025 By Sean Whooley

Insulet Omnipod 5 in Pool

Insulet (Nasdaq:PODD) today announced a new Diabetes Awareness Month campaign called “The Day Diabetes Showed Up to Work.” The American Diabetes Association (ADA) Diabetes Awareness Month begins on Nov. 1. World Diabetes Day is also coming up on Nov. 14, marking the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Diabetes Awareness Month 2024, Insulet

Tidepool announces new permanent CEO appointment

October 29, 2025 By Sean Whooley

Brandon Arbiter Tidepool CEO

Tidepool announced today that it appointed Brandon Arbiter as its CEO, following a six-month stint as the company’s interim CEO. Arbiter served as acting CEO since April 2025 after founder and CEO Howard Look stepped down to focus on his health. He previously held the post of VP of business development and strategic partnerships at […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Technology Tagged With: Personnel Moves, tidepool

Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus

October 29, 2025 By Sean Whooley

Tandem Diabetes Care t-slim X2 wearer with the Abbott FreeStlye Libre 3 Plus (1)

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus CGM. The new pairing combines Tandem’s flagship automated insulin delivery system with Control-IQ+ technology with Abbott’s latest continuous glucose monitor (CGM) sensor in the U.S. Tandem teased the launch on social media earlier […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Tandem Diabetes Care

Beta Bionics stock rises on Q3 beats, raised full-year guidance, advances iLet offerings

October 28, 2025 By Sean Whooley

Beta Bionics Logo (1)

Beta Bionics (Nasdaq:BBNX) shares got a boost after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of BBNX rose around 20% to $29 apiece in post-market trading today. The Irvine, California-based automated insulin delivery device maker reported losses of $14 million. That equals 33¢ per share on sales of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Beta Bionics

Glucose monitor maker LifeScan is set to emerge from Ch. 11 bankruptcy

October 28, 2025 By Sean Whooley

LifeScan OneTouch app

LifeScan announced that its Chapter 11 bankruptcy reorganization plan received U.S. Bankruptcy Court approval. The U.S. Bankruptcy Court for the Southern District of Texas approved the company’s Chapter 11 plan. With the approval, LifeScan said it’s positioned to emerge from its financial restructuring process by the end of the year. Malvern, Pennsylvania-based LifeScan said in […]

Filed Under: Business/Financial News, Diabetes, Featured, Legal News, Patient Monitoring, Technology, Wall Street Beat Tagged With: lifescan

ViCentra adds Dexcom, Medtronic Diabetes veterans to leadership team

October 28, 2025 By Sean Whooley

ViCentra Karen Baxter Jay Little headshots

ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles. The Dutch insulin pump maker continues to expand its senior leadership as it looks to advance its Kaleido patch pump system. It appointed Karen Baxter, former VP and GM at Dexcom, to the position of SVP of sales for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Technology Tagged With: Personnel Moves, ViCentra

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Interim pages omitted …
  • Page 203
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS